Effects of storage at -20°C on ischaemia-modified albumin results

Annals of Clinical Biochemistry

Volumn 43, Issue 6, 2006, Pages 500-502

  Beetham, R ^a   Monk, C ^a   Keating, L ^b   Benger, J R ^c,d   Kendall, J ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ISCHEMIA MODIFIED ALBUMIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; STORAGE; TEMPERATURE SENSITIVITY; THORAX PAIN;

FREEZING; HUMANS; ISCHEMIA; SERUM ALBUMIN; SPECIMEN HANDLING;

EID: 33751317001     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306778904669     Document Type: Article

References (14)

1. 2+ binding amino-acid residues of the N-terminus of human albumin. Eur J Biochem 2001; 268: 42-7
2. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2000; 19: 311-15
3. Christenson RH, Hong Duw S, Sanhai WR, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001; 47: 464-70
4. Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003; 49: 581-5
5. Morrow DA, de Lemos JA, Sabatine MS, Antman EM. The search for a biomarker of cardiac ischemia. Clin Chem 2003; 49: 537-9
6. Sacchetti A. 'Ischemia modified albumin': a new biochemical marker of myocardial ischemia. Emerg Med J 2004; 21: 3-4
7. Adams J. Markers to define ischemia: are they ready for prime time use in patients with acute coronary syndromes? Curr Cardiol Rep 2004; 6: 253-8
8. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski J-C. Role of 'ischemia modified albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21: 29-34
9. Troxler M, Thompson D, Homer-Vanniasinkim S. Ischaemic skeletal muscle increases serum ischaemia modified albumin. Eur J Vasc Endovasc Surg 2005; 31: 164-9
10. Bar-Or D, Winkler JV, VanBenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001; 141: 985-9
11. R plus analyzer. Clin Chem Lab Med 2004; 42: 455-61
12. Keating L, Benger JR, Beetham R, et al. The PRIMA study: presentation IMA in the emergency department. Emerg Med J 2006; 23 (in press)
13. Lefevre GF. Analytical performance of the ACB test for ischemia on the Konelab 20. Clin Chem 2003; 49(Suppl 6): A33
14. Gaze DC, Crompton L, Collinson PO. Sample stability of ischemia modified albumin (IMA) assessed by the albumin cobalt binding (ACB) test. Clin Chem 2003; 49(Suppl 6): A40